[
  {
    "ts": null,
    "headline": "Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More",
    "summary": "BMRN and NVAX are in the spotlight this week following announcement agreement and regulatory update.",
    "url": "https://finnhub.io/api/news?id=b64ab3144de0e2c009d31d86550c35e3f1889fb5cd399fe10f4ef22a29f84ec0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747931700,
      "headline": "Biotech Stock Roundup: BMRN to Acquire INZY, NVAX Gains on Vaccine Approval & More",
      "id": 134659295,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "BMRN and NVAX are in the spotlight this week following announcement agreement and regulatory update.",
      "url": "https://finnhub.io/api/news?id=b64ab3144de0e2c009d31d86550c35e3f1889fb5cd399fe10f4ef22a29f84ec0"
    }
  },
  {
    "ts": null,
    "headline": "MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot",
    "summary": "Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.",
    "url": "https://finnhub.io/api/news?id=c7ad18a86cebcebe4968f6d6ce52017eb78d12a42dd8a3c5bd548846eca4d846",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747925280,
      "headline": "MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot",
      "id": 134658710,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.",
      "url": "https://finnhub.io/api/news?id=c7ad18a86cebcebe4968f6d6ce52017eb78d12a42dd8a3c5bd548846eca4d846"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna, Inc. (MRNA) Crashed Today",
    "summary": "We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other firms that are drenched in red today. Ten companies pulled back on Wednesday, booking hefty losses during the trading session, with investor sentiment weighed down by […]",
    "url": "https://finnhub.io/api/news?id=a01cede063109b09afecc92682cce2d7ede0116dc51d31cc6c6f8410a488d829",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747873911,
      "headline": "Why Moderna, Inc. (MRNA) Crashed Today",
      "id": 134648411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Firms Drenched in Red Today. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other firms that are drenched in red today. Ten companies pulled back on Wednesday, booking hefty losses during the trading session, with investor sentiment weighed down by […]",
      "url": "https://finnhub.io/api/news?id=a01cede063109b09afecc92682cce2d7ede0116dc51d31cc6c6f8410a488d829"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine",
    "summary": "Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for adults aged 50 years and older. In a brief press release on Wednesday, the company said that it had decided after consultation with the FDA. Moderna, Inc. (NASDAQ:MRNA) plans […]",
    "url": "https://finnhub.io/api/news?id=4252cbd84761dd9c3cfd1c0b3d6d46ca65fbfe119dbadaf2a6d67719dd11cf3e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747872944,
      "headline": "Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine",
      "id": 134648412,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for adults aged 50 years and older. In a brief press release on Wednesday, the company said that it had decided after consultation with the FDA. Moderna, Inc. (NASDAQ:MRNA) plans […]",
      "url": "https://finnhub.io/api/news?id=4252cbd84761dd9c3cfd1c0b3d6d46ca65fbfe119dbadaf2a6d67719dd11cf3e"
    }
  }
]